Mozarc Medical has filed a notice of an exempt offering of securities to raise $32,713,303.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Mozarc Medical is raising $32,713,303.00 in new funding. Sources indicate that as part of senior management Executive, Marty Lorenzo played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Mozarc Medical
Mozarc Medical is an independent company launched by Medtronic and DaVita in 2023. Mozarc Medical focuses exclusively on developing meaningful and innovative kidney health technologies globally that reimagine holistic kidney care for the future including kidney access solutions, home dialysis technologies, and advancements in acute therapies. Because patients, caregivers, clinicians — they all deserve better. We are here. We are ready. We are Mozarc Medical.
To learn more about Mozarc Medical, visit http://mozarcmedical.com/
Contact:
Marty Lorenzo, Executive
949-434-5013
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.